Respiratory Tract Neoplasms  >>  epirubicin  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT00658580: Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer

Completed
3
361
Europe
Cisplatin + etoposide, Epirubicin + ifosfamide + etoposide
European Lung Cancer Working Party
Small Cell Lung Carcinoma, Extensive Disease
12/13
02/15

Download Options